J9024 Injection atezolizumb 5mg hya-tqjs
J-Codes
Also known as: Atezolizumab biosimilar, Atezolizumab Hya-tqjs
Atezolizumab (Hya-tqjs biosimilar) administered by injection at 5 milligrams per dose; a biosimilar version of the programmed death-ligand 1 inhibitor.
Clinical Context
Biosimilar version of atezolizumab used for non-small cell lung cancer and other malignancies. Same mechanism of action as reference product.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.